K183320 is an FDA 510(k) clearance for the Ilumien Optis, Optis Integrated, Optis Mobile. This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).
Submitted by St. Jude Medical (Now Abbott Medical) (St. Paul, US). The FDA issued a Cleared decision on April 2, 2019, 123 days after receiving the submission on November 30, 2018.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..